Dow Jones

39 816,49

-0,47%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Anthera Pharmaceuticals Inc (CE) (ANTH)
Anthera Pharmaceuticals Inc (CE) (ANTH) Actualités

ANTH

Anthera Pharmaceuticals (CE) (ANTH)

Anthera Pharmaceuticals Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ANTH

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
12/09/2018	21h21	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
30/07/2018	22h45	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
27/07/2018	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
20/07/2018	22h28	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
20/07/2018	22h28	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
20/07/2018	22h28	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
17/07/2018	20h38	Edgar (US Regulatory)	(25)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
09/07/2018	23h08	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
27/06/2018	14h00	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
15/05/2018	22h00	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
12/03/2018	13h00	GlobeNewswire Inc.	Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/03/2018	14h30	GlobeNewswire Inc.	Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
06/03/2018	23h31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
06/03/2018	20h45	GlobeNewswire Inc.	Anthera Pharmaceuticals Deemed Compliant with Nasdaq Listing Criteria	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
05/03/2018	23h32	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
05/03/2018	22h05	GlobeNewswire Inc.	Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
22/02/2018	22h29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
08/02/2018	14h30	GlobeNewswire Inc.	Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference and SunTrust Robinson Humphrey’s 4th Annual Orp...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
05/02/2018	14h30	GlobeNewswire Inc.	Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
25/01/2018	22h30	GlobeNewswire Inc.	Anthera Receives Positive Nasdaq Listing Determination	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
22/01/2018	14h30	GlobeNewswire Inc.	Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura: Stud...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
18/01/2018	23h29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
11/01/2018	21h07	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (d/a)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
09/01/2018	23h15	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
09/01/2018	12h38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
08/01/2018	14h30	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Results of Special Meeting of Stockholders	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
03/01/2018	14h30	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Appointment of Patrick Murphy as Senior Vice President, Manufacturing	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
11/12/2017	14h30	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollp...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
04/12/2017	12h17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
29/11/2017	22h07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)